Inventor · disambiguated record
Cynthia Lander
Also filed as: LANDER CYNTHIA
7 granted patents·10 pending applications·11 citations·filing 2011–2019
77Inventor score
Top patents by PatentIndex Score
17 records- 0184US9642888B2Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix depositionLANDER CYNTHIA·Filed 2012·Granted May 9, 2017·7 cites·33 claims
- 0271US10336788B2Inhibition of cardiac fibrosis in myocardial infarctionMOERAE MATRIX INC·Filed 2014·Granted Jul 2, 2019·1 cites·14 claims
- 0368US9890200B2Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix depositionMOERAE MATRIX INC·Filed 2014·Granted Feb 13, 2018·1 cites·22 claims
- 0466US10087225B2Formulation of MK2 inhibitor peptidesMOERAE MATRIX INC·Filed 2016·Granted Oct 2, 2018·1 cites·37 claims
- 0566US9999655B2Use of MKS inhibitor peptide-containing compositions for treating non-small cell lung cancer with sameMOERAE MATRIX INC·Filed 2016·Granted Jun 19, 2018·1 cites·24 claims
- 0658US10562947B2Compositions and methods for preventing or treating diseases, conditions or processes characterized by aberrant fibroblast proliferation and extracellular matrix depositionMOERAE MATRIX INC·Filed 2017·Granted Feb 18, 2020·0 cites·25 claims
- 0755US2020172574A1Inhibition of cardiac fibrosis in myocardial infarctionMOERAE MATRIX INC·Filed 2019·Application pending·0 cites
- 0852US2019022169A1Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix depositionMOERAE MATRIX INC·Filed 2017·Application pending·0 cites
- 0945US2019031730A1Formulation of mk2 inhibitor peptidesMOERAE MATRIX INC·Filed 2018·Application pending·0 cites
- 1043US2018036331A1Treatment of drug resistant proliferative diseases with telomerase mediated telomere altering compoundsUNIV TEXAS·Filed 2017·Application pending·0 cites
- 1143US2011288036A1Methods for Treating or Preventing Vascular Graft FailureLANDER CYNTHIA·Filed 2011·Application pending·0 cites
- 1240US10500249B2Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix depositionMOERAE MATRIX INC·Filed 2015·Granted Dec 10, 2019·0 cites·16 claims
- 1340US2013115256A1Methods for treating or preventing vascular graft failureLANDER CYNTHIA·Filed 2011·Application pending·0 cites
- 1439US2019022176A1Use of mk2 inhibitor peptide-containing compositions for treating non-small cell lung cancer with sameMOERAE MATRIX INC·Filed 2018·Application pending·0 cites
- 1539US2019134153A1Immunomodulatory effect of inhaled kinase inhibitor peptides in lungMOERAE MATRIX INC·Filed 2018·Application pending·0 cites
- 1636US2015258192A1Compositions and methods for preventing or treating chronic lung allograft dysfunction (clad) and idiopathic pulmonary fibrosis (ipf)BROPHY COLLEEN·Filed 2015·Application pending·0 cites
- 1733US2014072613A1Compositions and Methods for Treating Cutaneous ScarringLANDER CYNTHIA·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Cynthia Lander files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →